Medicine
Escitalopram 5 mg/5 mL oral solution
Escitalopram 5 mg/5 mL oral solution is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Escitalopram
- Brand
- Sold under the generic name
- Strength
- 5 mg/5 mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 240 mL, 2 trays and 5 more
- Manufacturers
- Aurobindo PharmaIndiaCamber PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaChartwell RXAmneal PharmaceuticalsChartwell Governmental & Specialty RXRising Pharma Holdings
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AB10 Escitalopram
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 September 2011
- Identifiers
- RxCUI 351285DailyMed set ID 0458445b-e431-4c82-86b8-90373813c10a, 09894a38-4e3a-475d-96cd-c6c8ed87869a, ba60c357-8e61-4a3d-b1dc-25602dbbfc2a +4NDC 62135-729, 65162-705, 65862-248 +4Application ANDA090477, ANDA202227, ANDA079062 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 240 mL in 1 bottle | 65862-248-24 | Aurobindo PharmaIndia | 3 April 2012 |
| 240 mL in 1 bottle | 31722-569-24 | Camber PharmaceuticalsIndia | 12 June 2012 |
| 240 mL in 1 bottle | 33342-053-28 | Macleods PharmaceuticalsIndia | 31 March 2016 |
| 240 mL in 1 bottle | 65162-705-88 | Amneal Pharmaceuticals | 3 September 2011 |
| 2 tray in 1 box / 10 cup in 1 tray / 10 mL in 1 cup | 68999-729-24 | Chartwell Governmental & Specialty RX | 21 January 2026 |
| 2 tray in 1 box / 10 cup in 1 tray / 10 mL in 1 cup | 62135-729-24 | Chartwell RX | 26 February 2025 |
| 240 mL in 1 bottle | 62135-729-37 | Chartwell RX | 11 August 2023 |
| 240 mL in 1 bottle | 16571-769-24 | Rising Pharma Holdings | 3 April 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 August 2002 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Escitalopram
Clinical summary
Escitalopram is a serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older, among other approved uses. MedsAcross supplies Escitalopram for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EscitalopramFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lexapro prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Escitalopram 5 mg/5 mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.